Staff

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19

GENEVA, SWITZERLAND / ACCESSWIRE / June 16, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company with its...

MOBILion Systems Launches MOBIE: The First SLIM-Based High-Resolution Ion Mobility (HRIM) Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery

CHADDS FORDS, Pa., June 15, 2021 /PRNewswire/ -- MOBILion Systems Inc. has today announced the launch of its first commercial High-Resolution...

Therap continues to increase Quality Assurance and Compliance as well as provide Audit Solutions for Human Services Professionals with New Reporting Features in 2021

WATERBURY, Conn., June 15, 2021 /PRNewswire/ -- Providers in Home and Community-Based Services (HCBS), Long-Term Services and Supports (LTSS) and...

error: Content is protected !!